Literature DB >> 25147987

Intravascular crystal deposition: an early clue to the diagnosis of type 1 cryoglobulinemic vasculitis.

Bryan Gammon1, Michelle Longmire, Brittney DeClerck.   

Abstract

Cutaneous small vessel vasculitis (CSVV) is a nonspecific finding with an extensive differential diagnosis. It is critically important to distinguish skin-limited presentations of CSVV from severe life-threatening systemic vasculitides presenting with CSVV as an initial manifestation. It can be challenging to determine which patients presenting with CSVV are at risk for systemic disease. Standard histopathologic evaluation, direct immunofluorescence, and serologic evaluation is typically required to exclude a systemic vasculitis. Type 1 cryoglobulinemia may rarely present with CSVV. Herein, we report a case of type 1 cryoglobulinemia in the setting of occult multiple myeloma. CSVV with prominent intravascular crystal formation was noted. The presence of intravascular crystals in the setting of CSVV may represent an important early clue to the diagnosis of type 1 cryoglobulinemic vasculitis.

Entities:  

Mesh:

Year:  2014        PMID: 25147987      PMCID: PMC5906036          DOI: 10.1097/DAD.0b013e31829ff8d9

Source DB:  PubMed          Journal:  Am J Dermatopathol        ISSN: 0193-1091            Impact factor:   1.533


  13 in total

1.  Cutaneous small vessel vasculitis: an entity with frequent renal involvement.

Authors:  Despina J Ioannidou; Konstantin Krasagakis; Eugene K Daphnis; Konstantinos E Perakis; Flora Sotsiou; Androniki D Tosca
Journal:  Arch Dermatol       Date:  2002-03

Review 2.  Cutaneous vasculitis: diagnosis and management.

Authors:  J Andrew Carlson; L Frank Cavaliere; Jane M Grant-Kels
Journal:  Clin Dermatol       Date:  2006 Sep-Oct       Impact factor: 3.541

3.  Diagnosis of type I cryoglobulinaemia made through identifying crystals in the blood smear.

Authors:  Kyoko Shirato; Catherine Reid; Jan S Ibbetson; Pravin Hissaria; Sidhu Shireen
Journal:  Australas J Dermatol       Date:  2009-11       Impact factor: 2.875

Review 4.  Cryoglobulinemia vasculitis: an update.

Authors:  Benjamin Terrier; Patrice Cacoub
Journal:  Curr Opin Rheumatol       Date:  2013-01       Impact factor: 5.006

Review 5.  Crystal-storing histiocytosis: report of a case, review of the literature (80 cases) and a proposed classification.

Authors:  Snjezana Dogan; Leon Barnes; Wilhelmina P Cruz-Vetrano
Journal:  Head Neck Pathol       Date:  2012-03-20

6.  Biologic and clinical significance of cryoglobulins. A report of 86 cases.

Authors:  J C Brouet; J P Clauvel; F Danon; M Klein; M Seligmann
Journal:  Am J Med       Date:  1974-11       Impact factor: 4.965

Review 7.  Crystalglobulin-induced vasculopathy accompanying ischemic intestinal lesions of a patient with myeloma.

Authors:  H Usuda; I Emura; M Naito
Journal:  Pathol Int       Date:  1996-02       Impact factor: 2.534

Review 8.  Cutaneous vasculitis update: diagnostic criteria, classification, epidemiology, etiology, pathogenesis, evaluation and prognosis.

Authors:  J Andrew Carlson; Bernard T Ng; Ko-Ron Chen
Journal:  Am J Dermatopathol       Date:  2005-12       Impact factor: 1.533

9.  Cryoglobulin crystal arthropathy in a patient with multiple myeloma.

Authors:  Alejandra C Rodriguez-Paez; Mythili Seetharaman; Lawrence H Brent
Journal:  J Clin Rheumatol       Date:  2009-08       Impact factor: 3.517

10.  Clinical and histopathologic spectrum of necrotizing vasculitis. Report of findings in 101 cases.

Authors:  N P Sanchez; H M Van Hale; W P Su
Journal:  Arch Dermatol       Date:  1985-02
View more
  2 in total

Review 1.  [A case of cryocrystalglobulinemia with microvascular embolization as the first manifestation and literature review].

Authors:  Y Fei; J Lu; H B Zhang; D J Li; N Tang
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2019-10-14

Review 2.  Type I cryoglobulinemic vasulitis with eosinophilia: A case report and literature review.

Authors:  Jingjing Wen; Fang Xu; Min Li; Qiaoling Zhou; Wen Qu; Yiping Liu; Jing Su; Hong Hu
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.